A new study published today in the journal Frontiers in Pharmacology found that cannabidiol (CBD) helped protect brain cells, reduce injury-related inflammatory responses and limit …
Category: CBD Studies
Peer-reviewed studies focused on the compound cannabidiol (CBD), which is a nonpsychoactive component of the cannabis plant.
Human Study Finds Topical CBD Oil Associated With 41% Reduction in Myofascial Pain After Two Weeks
A new human study involving 192 people with myofascial pain found that applying topical cannabidiol (CBD) oil was associated with progressively lower pain levels, culminating …
Study Finds CBD Selectively Suppresses Breast Cancer Cells While Stimulating Non-Tumor Cells
Cannabidiol (CBD) selectively reduced activity and adhesion in human breast cancer cells while stimulating activity in non-tumor breast cells, according to a new laboratory study. …
Study Finds Regular CBD Users Slept Longer, Had More REM Sleep and Lower Peak Heart Rates
Regular cannabidiol (CBD) users slept significantly longer, spent more time in rapid eye movement (REM) sleep and recorded lower maximum heart rates than nonusers in …
Study Finds Low-Dose THC and CBD Work Synergistically to Reduce Sickle Cell Pain
A new study using a humanized mouse model of sickle cell disease found that low doses of THC and CBD worked synergistically to reduce pain, …
Systematic Review Finds THC-CBD Improves Acute Migraine Outcomes, Full-Spectrum Cannabis Extract Helps Chronic Back Pain
A systematic review of randomized clinical trials involving more than 1,000 patients found moderate-certainty evidence supporting vaporized THC and CBD for acute migraine and a …
CBD-Chemotherapy Combination Shows Enhanced Activity Against Human Ovarian Cancer Cells
A combination of cannabidiol (CBD) and the chemotherapy drug epirubicin delivered through a nanoparticle-based carrier showed significantly greater activity against human ovarian cancer cells than …
Phase III CBD Heart Disease Trial Expands After Blinded Review Finds Fewer Pericarditis Recurrences Than Expected
A Phase III clinical trial testing a cannabidiol (CBD) formulation for recurrent pericarditis is being expanded after a blinded review found fewer disease recurrences than …















